2022 annual financial data
Sarepta Therapeutics 2022 Operating margin
Sarepta Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -57.47%.
Operating income was -536,201,000 USD and net income was -703,488,000 USD.
Operating cash flow was -325,346,000 USD.
Get free Sarepta Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 933,013,000 USD
- Operating income
- -536,201,000 USD
- Net income
- -703,488,000 USD
- Operating cash flow
- -325,346,000 USD